These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 15134519)
1. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents. Jung M; Lee K; Kim H; Park M Curr Med Chem; 2004 May; 11(10):1265-84. PubMed ID: 15134519 [TBL] [Abstract][Full Text] [Related]
2. C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene. Ekthawatchai S; Kamchonwongpaisan S; Kongsaeree P; Tarnchompoo B; Thebtaranonth Y; Yuthavong Y J Med Chem; 2001 Dec; 44(26):4688-95. PubMed ID: 11741486 [TBL] [Abstract][Full Text] [Related]
3. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083 [TBL] [Abstract][Full Text] [Related]
4. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. Posner GH; Ploypradith P; Parker MH; O'Dowd H; Woo SH; Northrop J; Krasavin M; Dolan P; Kensler TW; Xie S; Shapiro TA J Med Chem; 1999 Oct; 42(21):4275-80. PubMed ID: 10543871 [TBL] [Abstract][Full Text] [Related]
5. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chaturvedi D; Goswami A; Saikia PP; Barua NC; Rao PG Chem Soc Rev; 2010 Feb; 39(2):435-54. PubMed ID: 20111769 [TBL] [Abstract][Full Text] [Related]
6. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin. Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells. Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263 [TBL] [Abstract][Full Text] [Related]
8. Heme as trigger and target for trioxane-containing antimalarial drugs. Meunier B; Robert A Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120 [TBL] [Abstract][Full Text] [Related]
9. Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. Posner GH; McRiner AJ; Paik IH; Sur S; Borstnik K; Xie S; Shapiro TA; Alagbala A; Foster B J Med Chem; 2004 Feb; 47(5):1299-301. PubMed ID: 14971910 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs. Mott BT; Tripathi A; Siegler MA; Moore CD; Sullivan DJ; Posner GH J Med Chem; 2013 Mar; 56(6):2630-41. PubMed ID: 23425037 [TBL] [Abstract][Full Text] [Related]
11. Qinghaosu (artemisinin): chemistry and pharmacology. Li Y Acta Pharmacol Sin; 2012 Sep; 33(9):1141-6. PubMed ID: 22922345 [TBL] [Abstract][Full Text] [Related]
12. Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria. Peter S; Jama S; Alven S; Aderibigbe BA Molecules; 2021 Dec; 26(24):. PubMed ID: 34946603 [TBL] [Abstract][Full Text] [Related]
13. Artemisinin and its derivatives: an important new class of antimalarial agents. Balint GA Pharmacol Ther; 2001; 90(2-3):261-5. PubMed ID: 11578659 [TBL] [Abstract][Full Text] [Related]
14. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives. Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646 [TBL] [Abstract][Full Text] [Related]
15. Artemisinin and Its Derivatives as Potential Anticancer Agents. Wen L; Chan BC; Qiu MH; Leung PC; Wong CK Molecules; 2024 Aug; 29(16):. PubMed ID: 39202965 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. Avery MA; Muraleedharan KM; Desai PV; Bandyopadhyaya AK; Furtado MM; Tekwani BL J Med Chem; 2003 Sep; 46(20):4244-58. PubMed ID: 13678403 [TBL] [Abstract][Full Text] [Related]
17. Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin. Corsello MA; Garg NK Nat Prod Rep; 2015 Mar; 32(3):359-66. PubMed ID: 25342519 [TBL] [Abstract][Full Text] [Related]
18. Biological Activities of Artemisinin Derivatives Beyond Malaria. Liu X; Cao J; Huang G; Zhao Q; Shen J Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260 [TBL] [Abstract][Full Text] [Related]
19. Total Synthesis and Biological Investigation of (-)-Artemisinin: The Antimalarial Activity of Artemisinin Is not Stereospecific. Krieger J; Smeilus T; Kaiser M; Seo EJ; Efferth T; Giannis A Angew Chem Int Ed Engl; 2018 Jul; 57(27):8293-8296. PubMed ID: 29723442 [TBL] [Abstract][Full Text] [Related]